Congenital Rubella Infections among the Pregnant Women at a Tertiary Care Hospital in Karachi, Pakistan

Main Article Content

Madiha Sattar
Urooj Ibrahim
Sehrish Ilyas
Safia Bibi
Ghulam Fatima

Abstract

Introduction: Rubella virus is an important human pathogen that causes an acute and contagious disease known as rubella and also, causes congenital rubella syndrome more commonly occur during the first trimester of pregnancy. The incidence of CRS varies in different populations and the highest burden found in developing countries where rubella vaccination is not included in their national immunization programs. Therefore, the aim of this study was to determine the burden of CRS-related birth defects and its incidence in the pre-vaccine era in Karachi Pakistan.

Objective: The aim of the study to determine the rate of congenital rubella infection among the pregnant women at a Tertiary Care Hospital.

Methods: The retrospective descriptive cross sectional study was conducted in different departments of Dr Ruth PFAU Civil Hospital Karachi, including Eye OPD and Pediatric units from Jan 2016 till December 2019. The medical records of clinically suspected infants or confirmed cases were reviewed. The confirmed cases were positive for maternal IgM rubella antibodies and tested by ELISA (Enzyme Linked immunosorbant assay) where as the rubella IgM antibodies in suspected infants were lost to follow. Inclusion criteria were infants admitted less than or equal to 1 year of age with history of either congenital cataract, congenital glaucoma, pigmented retinopathy, congenital heart defects like (patent ductus arteriosus, periphery pulmonary stenosis, ventricular septal defects), hearing impairment, deafness or microcephaly were included in the study.

Results: Out of total 142 infants that were admitted in the hospital during 4 years period from 2016 to 2019 only 7 (4.93%) infants were diagnosed as confirmed cases of congenital rubella infection where as 14 (9.86%) infants were found to be clinically suspected. The ocular manifestation were more common among 6 infants which presented with cataract (85.7%) and 2 infants presented with pigmented retinopathy (28.6%). Besides this other manifestations like developmental delay were seen in only 2 patients DD (28.6%) and 3 infants presented with congenital heart diseases CHD (42.9%). The combinations of clinical features of congenital heart defect with cataract and developmental delay were seen in only 1 infant whereas cataract with pigmented retinopathy and developmental delay was seen in 1 infant and 2 infants presented with combination of congenital heart defects and cataracts.

Conclusion: Our study reported the rate of congenital rubella infection was 4.93% in a four years study period. Therefore, with a rising trend in congenital rubella infections in the last past years there is a need to built strong surveillance system and to introduce a childhood immunization in the national immunization program to eliminate the Rubella infection.

Keywords:
Congenital Heart Diseases (CHD), Enzyme Linked Immuno Sorbent Assay (ELISA), Pigmented Retinopathy (PR), Developmental Delay (DD).

Article Details

How to Cite
Sattar, M., Ibrahim, U., Ilyas, S., Bibi, S., & Fatima, G. (2020). Congenital Rubella Infections among the Pregnant Women at a Tertiary Care Hospital in Karachi, Pakistan. South Asian Journal of Research in Microbiology, 7(2), 41-45. https://doi.org/10.9734/sajrm/2020/v7i230168
Section
Original Research Article

References

Al Hammoud R, Murphy JR, Pérez N. Imported congenital rubella syndrome, United States, 2017. Emerging infectious diseases. 2018;24(4):800-801.

Yazigi A, De Pecoulas AE, Vauloup-Fellous C, Grangeot-Keros L, Ayoubi JM, Picone O. Fetal and neonatal abnormalities due to congenital rubella syndrome: A review of literature. The Journal of Maternal-Fetal & Neonatal Medicine. 2017;30 (3):274-278.

Bouthry E, Picone O, Hamdi G, Grangeot‐Keros L, Ayoubi JM, Vauloup‐Fellous C. Rubella and pregnancy: Diagnosis, management and outcomes. Prenatal diagnosis. 2014; 34(13):1246-1253.

Kaushik A, Verma S, Kumar P. Congenital rubella syndrome: A brief review of public health perspectives. Indian Journal of Public Health. 2018; 62(1):52.

Vauloup-Fellous C. Standardization of rubella immunoassays. Journal of Clinical Virology. 2018;102:34-38.

Dinede G, Wondimagegnehu A, Enquselassie F. Rubella outbreak in the school children, Addis Ababa, Ethiopia: February–April 2018. BMC Infectious Diseases. 2019;19(1):267.

Obam Mekanda FM, Monamele CG, Simo Nemg FB, Sado Yousseu FB, Ndjonka D, Kfutwah AK, Abernathy E, Demanou M. First report of the genomic characterization of rubella viruses circulating in Cameroon. Journal of Medical Virology. 2019;91(6): 928-934.

Rubella and congenital rubella syndrome control and elimination - global progress, 2000-2014. Wkly Epidemiol Rec. 2015;90: 510.

Binnicker MJ, Jespersen DJ, Harring JA. Multiplex detection of IgM and IgG class antibodies to Toxoplasma gondii, rubella virus, and cytomegalovirus using a novel multiplex flow immunoassay. Clin. Vaccine Immunol. 2010;17(11):1734-1738.

Lawn JE, Cousens S, Zupan J, Lancet Neonatal Survival Steering Team. Four million neonatal deaths: When? Where? Why? Lancet. 2005;365:891-900.

Rathore PK, Kumar A, Vyas A, Bareja R, Dalal AS. Incidence of rubella antibodies among pregnant women in a tertiary care hospital. Journal of Pharmaceutical and Biomedical Sciences. 2016;6(2):110-114.

Nessa A, Tabassum S, Akther T, Sultana N, Selim S. Rubella antibody prevalence and immunogenicity of single dose rubella vaccine among 16-25 years girls from Bangladesh. Bangladesh Med Res Counc Bull. 2016;42:84-9.

Nageen H, Ghazala J, Shahida H, Anwar MS. Seroprevalence of rubella IgG and IgM antibodies in infants suspected of having rubella infection. Bio med. 2006;22: 25-30.

Khan A, Rahman H, Noushin R, Anjum SI, Saad F, Ullah K. Rubella seroprevalence and demographic feature analysis in pregnant women from Southern Pakistan. J Pak Med Assoc. 2019;69(8):959-963.

Ahmed MU. IgM and IgG antibodies specific to rubella in child bearing women. J. Pak. Med. Assoc. 1992;42(5):121- 122.

Webster WS. Teratogen update: Congenital rubella. Teratology. 1998;58:13.

Lee H, Kayano T, Nishiura H. Predicting congenital rubella syndrome in Japan, 2018–2019. International Journal of Infectious Diseases. 2019;82:1-5.

Neto EC, Rubin R, Schulte J, Giugliani R. Newborn screening for congenital infectious diseases. Emerging Infectious Diseases. 2004;10(6):1069-1073.

Reef SE, Cochi SL. The evidence for the elimination of rubella and congenital rubella syndrome in the United States: a public health achievement. Clin Infect Dis. 2006;43(Suppl 3):S123.

Givens KT, Lee DA, Jones T, Ilstrup DM. Congenital rubella syndrome: Ophthalmic manifestations and associated systemic disorders. British Journal of Ophthalmology. 1993;77(6):358-363.

Toizumi M, Nguyen GT, Motomura H, Nguyen TH, Pham E, Kaneko KI, Uematsu M, Nguyen HA, Dang DA, Hashizume M, Yoshida LM. Sensory defects and developmental delay among children with congenital rubella syndrome. Scientific Reports. 2017;7:46483.